Tuesday, June 23, 2020 9:08:41 AM
I came up with similar numbers
The arithmetic is simple, the challenge is determining the right multiple and time required to ramp to the max production of 1500 units. Obviously, if they do produce 1500 units/week, that leads to some very big numbers in terms of revenue and profit (and they would likely generate greater than 25% net margin assuming some operating leverage). The margins on filters are likely to be significantly above the purifier units, but I don't believe they've provided guidance.
I think a 15 PE multiple is too low, but not trying to argue that point as you made an assumption. I would argue for a higher multiple based on the anticipated growth rate AND the opportunity to sell filters. This creates a long-tailed revenue stream of recurring revenue, which reduces risk (risk is another key variable in determining PE multiples).
All boils down to execution now from what I can tell. I think selling part of the business to a better capitalized third party makes sense at this juncture to ensure adequate funding to grow. I anticipate that the share price will settle somewhere in the range you outlined. It likely overshoots initially and then settles back.
Thanks for sharing your thoughts.
The arithmetic is simple, the challenge is determining the right multiple and time required to ramp to the max production of 1500 units. Obviously, if they do produce 1500 units/week, that leads to some very big numbers in terms of revenue and profit (and they would likely generate greater than 25% net margin assuming some operating leverage). The margins on filters are likely to be significantly above the purifier units, but I don't believe they've provided guidance.
I think a 15 PE multiple is too low, but not trying to argue that point as you made an assumption. I would argue for a higher multiple based on the anticipated growth rate AND the opportunity to sell filters. This creates a long-tailed revenue stream of recurring revenue, which reduces risk (risk is another key variable in determining PE multiples).
All boils down to execution now from what I can tell. I think selling part of the business to a better capitalized third party makes sense at this juncture to ensure adequate funding to grow. I anticipate that the share price will settle somewhere in the range you outlined. It likely overshoots initially and then settles back.
Thanks for sharing your thoughts.
Recent VYST News
- Vystar Plans Dividend Spin Off of RXAIR and Related Brands Following R3alm, Inc. Transaction • GlobeNewswire Inc. • 04/27/2026 12:00:00 PM
- Vystar and R3alm Launch R3alm.com Following Strategic Transaction • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. • GlobeNewswire Inc. • 04/20/2026 01:22:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM
